Compared side by side

TB-500 vs KPV: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

They cover different parts of healing: TB-500, the 7-amino-acid stretch of thymosin beta-4 that binds actin, helps repair cells reach injured tissue, and KPV, three amino acids from the tail of α-MSH, blocks NF-κB, the master switch for inflammatory signals, in cell and mouse studies. TB-500’s own research is a few animal studies, and no human study has tested KPV. TB-500 runs with a twice-weekly loading phase; KPV is taken daily, by injection or by mouth.

Side by side

ComparedTB-500KPV
CategoryHealing & recoveryHealing & recovery
Also known asThymosin Beta-4 Fragment, TB4Lys-Pro-Val, α-MSH tripeptide
What it isA fragment of thymosin beta-4, a protein your body uses for cell repair.One of the smallest bioactive peptides: three amino acids from the tail end of α-MSH.
How it worksSynthetic fragment of Thymosin Beta-4: Ac-LKKTETQ, the 7-amino-acid stretch (residues 17–23) that binds actin. The whole protein holds actin building blocks back from forming filaments, a reserve cells draw on when they move. In lab and rodent studies the fragment drew blood-vessel cells, sped wound repair in aged mice and strengthened repaired tendons in rats; the anti-inflammatory findings are for the whole protein. Loading phase 2x/week then drop to maintenance.C-terminal tripeptide of α-MSH. A potent anti-inflammatory in cell and mouse studies that works mainly inside cells rather than through melanocortin receptors: it enters through the PepT1 transporter and blocks NF-κB signaling. In mice it eased colitis and damped allergic skin reactions; as eye drops it sped corneal wound healing in rabbits; in lab dishes it slowed Staphylococcus aureus and Candida albicans.
Commonly reportedStubborn soft-tissue injuries loosening up, with range of motion returning over a few weeks. Its own research is a few animal studies; the human trials tested the whole protein. Often paired with BPC-157.A calmer gut and calmer skin. No human study has tested it yet.
Studied rangeResearch range: 1–2.5 mg. Studied in research — not a recommendation.Research range: 100–300 mcg. Studied in research — not a recommendation.
How often2x/week loading, 1–2mg/week maintenanceDaily
Half-life~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people)Not measured: no half-life for KPV has been published, in people or animals
RouteSubQ injection, IM injectionSubQ injection, Oral
Typical runLoading phase 2x/week for 4–6 weeks, then maintenance 1x/week or stop. Common to cycle 6–8 weeks on, time off.4–8 weeks typical for gut protocols. Can reassess after each cycle.
EvidenceEmerging: primarily preclinical / limited human dataEmerging: primarily preclinical / limited human data
Common side effectsInjection site reaction, fatigue, nausea, headache, lethargyInjection site irritation, mild nausea

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking TB-500 or KPV? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

TB-500

  • Day 1–7 Week one: set your baseline
  • Day 7–14 Stiffness often starts to ease
  • Day 14–28 Load tolerance often picks up
  • Day 28–42 Gains slow, repair keeps going
  • Day 42–56 Weeks 6 to 8: how far it's come

Every card for TB-500, with its sources

KPV

  • Day 1–7 Week one: your starting point
  • Day 7–21 Users often report a calmer gut
  • Day 21–42 Some report calmer skin
  • Day 42–56 Weeks 6 to 8: taking stock

Every card for KPV, with its sources

Together or one or the other

TB-500 and KPV are a common stack: they’re together in the KLOW stack.

  • KLOW: GLOW plus KPV — four repair peptides in one vial (KPV, BPC-157, TB-500 and GHK-Cu).

Questions people ask

How long do TB-500 and KPV last?

The half-life of TB-500 is ~0.5–2 hours (measured for the whole protein, thymosin beta-4, given IV to healthy volunteers; TB-500 itself has never been measured in people). The half-life of KPV is not measured: no half-life for KPV has been published, in people or animals.

How often are TB-500 and KPV taken?

TB-500: 2x/week loading, 1–2mg/week maintenance. Routes: SubQ injection, IM injection. KPV: daily. Routes: SubQ injection, oral.

How are TB-500 and KPV dosed in research?

The research range for TB-500 is 1–2.5 mg. The research range for KPV is 100–300 mcg. Studied in research — not a recommendation.

What are the common side effects of TB-500 and KPV?

For TB-500, the library lists: injection site reaction, fatigue, nausea, headache, lethargy. For KPV: injection site irritation, mild nausea.

Are TB-500 and KPV taken together?

TB-500 and KPV are a common stack: they’re together in the KLOW stack.

Each one in full

Track it in the app

PepVault for iPhone

Taking TB-500 or KPV? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo